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Human cytomegalovirus (CMV) is the most common cause of congenital and perinatal infections.  
Understanding the epidemiology of CMV is a key element in development of strategies for prevention of 
infection in premature infants.  Breast-fed infants are susceptible to CMV infection from breast milk.  
CMV was isolated more frequently from breast milk at more than one month after delivery than from 
colostrum or early breast milk.  CMV particle shedding into milk whey have a more important role.  
Cytokines in serum and milk are related to the reactivation of CMV, which occurs locally in the 
mammary gland of the lactating mother after delivery.   Premature infants with low concentration of 
serum antibodies can acquire CMV infection from the fresh breast milk containing the virus. Freezing 
breast milk may be protective for the preterm infant until the titer of CMV antibody increases.  However 
clinical importance of CMV infection in premature infants by breast-feeding is still unclear.  This mini-
review focuses on recent advances in the study of CMV infection in premature infants by breast-
feeding. 
                            





Human cytomegalovirus (CMV) is the most common 
cause of congenital and perinatal infections throughout 
the world.     
The prevalence of congenital CMV infection varies 
widely between different populations (0.2-3.0%).  Only 
less than 5% of the infants with congenital CMV infection 
have typical clinical symptoms of cytomegalic inclusion 
disease (CID), another 5% have atypical involvement, 
and the remainder (90%) is asymptomatic at the time of 
delivery (Numazaki and Chiba, 1997). Even 
asymptomatic at birth,
 
5 to 17% of infants with these 
asymptomatic congenital CMV infections will develop 
progressive sensorineural hearing loss or other 
neurodevelopmental difficulties within first 4 years  of  life  
after birth (Numazaki et al., 2002; Numazaki and 
Fujikawa, 2004).  
We previously reported the incidence of congenital 
CMV infection in Japan (Numazaki and Chiba, 1996).Of 
7, 995 Japanese neonates, 31 (0.39%) were identified as 
having congenital CMV infections on the basis of viuria at 
birth.Three of 31 infants had clinically severe disease 
resulting in death during the neonatal period.  As 
decrease in the prevalence of serum antibodies against 
CMV has been speculated in recent years in the last 20 
years (Nishimura et al., 1999), the incidence of primary 
infection during pregnancy may be increased in future.  
Transmission of CMV by natural routes relates 
importantly to preventing CMV transmission to the 
seronegative pregnant women. CMV is isolated more 
frequently from cervical secretion and semen than from 
urine and other clinical specimens.  Evidences for sexual 
transmission of CMV were provided by determining 
prevalence of serum antibodies to CMV and viral 
shedding in male sex partners of women with and 
without CMV infection (Numazaki at al., 2000).   
However, it is also necessary to take into account other 
potential sources of CMV infection including contact with 
asymptomatic young children who are excreting CMV at 
the places such as child care arrangements. 
Primary infection of CMV during pregnancy was 
associated with an increased risk of developmental or 
intellectual deficit in the offspring.  Although CMV can be 
transmitted to the fetus even if there is preconceptional 
maternal   immunity,   reinfection   or   reactivated   latent  




infection might be an important determinant of 
developmental and intellectual impairment in the 
offspring.The population of seropositive women of 
childbearing age in low socioeconomic community is 
about 85% and about 55% in populations of high 
socioeconomic status.
 
In certain countries parental 
interest groups have called for screening programs for 
the general obstetric population in an attempt to reduce 
the rate of fetal damage with congenital CMV infection. 
Although social and economic conditions have 
improved dramatically, it was also reported that the 
prevalence of CMV was stable from 1976 to1990 (Hirota 
et al., 1992).   The prevalence of serum antibodies to 
CMV was decreased and primary CMV infection during 
pregnancy was speculated to be increased in Sapporo, 
Japan during the time of 1988 to 2000 (Numazaki and 
Fujikawa, 2002). From the results of the recent study, 
incidences of congenital CMV infection in Japan are 
estimated to be changed (Numazaki and Fujikawa, 
2004).  
Breast-fed infants are susceptible to CMV infection 
from breast milk.  Premature infants with low 
concentration of serum antibodies can acquire CMV 
infection from the fresh breast milk containing the virus.  
Freezing breast milk may be protective for the preterm 
infant until the titer of CMV antibody increases.   
However clinical importance of CMV infection in 
premature infants by breast-feeding is not completely 
clarified.  This mini-review focuses on recent advances in 
the study of CMV infection in premature infants by 
breast-feeding relevant for clinicians. 
 
 
Epidemiology of perinatal CMV Infections  
 
As a result of transmission during the course of delivery 
and by ingestion of infected breast milk, perinatal 
infections are much more prevalent than congenital 
infections. Perinatal CMV infection often involves the 
hepatobiliary tract but does not usually cause clinical 
manifestations in normal individuals.  Seropositivity for 
antibodies against CMV is indicative of latent infection, 
but insufficient as a predictor for the risk of recurrence.In 
seronegative preterm infants it has been possible to 
prevent postnatal CMV transmission by screening blood 
products for CMV and treating banked breast milk (Diosi 
et al, 1967).The reported rate of transmission for infants 
fed with CMV-positive breast milk ranges from 58 to 76% 
(Hayes et al., 1972; Dworsky et al., 1983; Hotsubo et al., 
1994).  
Liver dysfunction associated with perinatal CMV 
infections is often recognized in both normal and immuno 
compromised hosts and in patients with both primary and  
reactivated CMV infections. Although infantile CMV 
hepatitis was speculated to be caused by primary 
infection in the perinatal period, immunological conditions 
of the hosts may modify the clinical manifestations. We 





cells, especially CD4+ and CD8+ T lymphocytes, in 
infants with liver dysfunction associated with perinatal 
primary CMV infection, by flow cytometry and the 
polymerase chain reaction (PCR) (Numazaki et al., 
1994). Expression of CMV antigens in CD4+ and CD8+ 
cells was also found in patients with liver dysfunction 
associated with perinatal primary CMV infection.  CMV 
infection of CD4+ and CD8+ cells may play an important 
role in the pathogenesis of activation of CMV infection 
(Fujikawa et al, 2003a, b).  
 
 
CMV infections by breastfeeding 
 
Since Diosi et al. (1967) succeeded in isolating CMV 
from breast milk, breast milk has been considered as one 
of the most important sources of mother-to-infant 
infection.  Hayes et al. (1972) isolated CMV from breast 
milk of 17 out of 64 seropositive women (27%) and most 
of the isolates were obtained after the first week.  Stagno 
et al. (1980)
 
reported that breast-fed infants are more 
frequently infected with CMV than bottle-fed infants by 
the result of isolation from urine.  Dworsky et al. (1983) 
reported that consumption of infected breast milk led to 
infection in 69% of infants.  
The presence of CMV in breast milk was more 
frequently observed than in other sites such as vaginal 
secretion, urine and saliva.  Isolation of CMV from 
colostrum around the time of delivery showed a lower 
incidence of viral isolation than breast milk at more than 
one month after delivery. Breastfeeding seemed to be 
associated more closely with vertical infection than 
contact with an infected genital tract.  Infants who were 
fed on breast milk for over one month were infected more 
frequently, and the incidence of infection in infants was 
significantly higher when the infants were fed by mothers 
who shed CMV into their milk (Dworsky et al., 1983).   
We compared the rates of CMV isolation from breast 
milk at different times after delivery.  Our data support 
the results of previous studies (Hayes et al., 1972; 
Dworsky et al., 1983; Hotsubo et al., 1994; Ahlfors et al., 
1985) which show that virus excretion into colostrum and 
milk occurs less frequently in the period a few weeks 
after delivery.  Our results of the detection of CMV 
immediate early (IE) DNA (Asanuma et., 1996) also 
support the data of isolation.   
Colostrum and early milk were previously reported to 
contain abundant I gA and I gM that might be capable of 
neutralizing CMV during the first few days of lactation 
(Goldman et al., 1982).
 
However, IgA and IgM antibodies 
against CMV are not associated with diminished CMV 
shedding in colostrum and early milk, as CMV DNA has 




Although lactoferrin and other iron-binding proteins 
present in colostrum and milk also have bacteriostatic 





vivo roles of these antiviral agents in neonatal and 
maternal infections has yet to be clarified.The synergistic 
interaction between sIgA and iron-binding proteins such 
as lactoferrin has been speculated to have an important 
role in such defense (Skansn-Saphir et al., 1993). As 
viral DNA was not detected from colostrum and no anti-
CMV effects of liquid supernatant of colostrum was 
shown, inhibitory effect of antibodies in colostrum was 
not proved (Numazaki et al., 1996).
 
 
Most of the viruses in the human herpesvirus family 
are transmitted by cell-to-cell contact.  Cell-to cell contact 
is also the main method of vertical transmission for 
human T-lymphotropic virus type-I (HTLV-I) and human 
immunodeficiency virus type-1 (HIV-1) (Kinoshita et al., 
1984; Van de Perre et al, 1993).  For most viruses 
including CMV, although transmission has been 
documented, no serious illness or clinical symptoms in 




Human breast milk contains many different types of 
cells associated with immune reactions. Although CMV 
DNA was detected in milk cells, the rate of detection in 
whey was higher than in milk cells. CMV particle 
shedding into whey may have a more important role in 
vertical infection by breast milk than cell-to-cell 
transmission. The excretion of CMV into breast milk was 
not considered to be the primary CMV infection of 
mothers. 
Mononuclear cells of human breast milk have a 
potential for production of many different cytokines 
including tumor necrosis factor (TNF)-(),and interferon 
(IFN)- () (Goldman et al., 1982; Skansen-Saphir et al., 
1993).  It is likely that specific cellular interactions as well 
as other cytokines are necessary for CMV reactivation 
(Numazaki et al., 1998; Asanuma et al., 1995). In the 
active phase of CMV infection, serum titers of sIL-2R 
were correlated with clinical findings.   
In postpartum women, the state of cellular immunity is 
thought to be similar to the state in late pregnancy.  The 
suppression of cellular immunity is thought to induce a 
localized reaction in the mammary gland and to induce a 
large amount of CMV shedding into the colostrum.  It 
was suggested that presence of cytokines such sIL-2 in 
serum was also related to the reactivation of CMV which 
occurs locally in the mammary gland of the lactating 
mother after delivery.   
We also tried to evaluate anti-CMV properties and 
roles of cytokines in human colostrum and breast milk 
(Numazaki et al., 1997).
 
  Anti-CMV activity of colostrum 
was evaluated by indirect immunofluorescence assay 
using CMV AD169 strain-infected MRC-5 cells. We 
measured TNF-()and IFN-()activities in breast milk.   
Liquid supernatant of colostrum without cytotoxicity 
was not found to exert inhibitory effect on CMV-infected 
MRC-5 cells. The activities of TNF-() were detected in 
CMV DNA-negative colostrum and breast milk. These 
activities were not detected from CMV DNA-positive   




milk.  IFN-() activities were also detected in colostrum. It 
is likely that presence of cytokines such as TNF-()  and 
IFN-() in colostrum and early breast milk are related to 
inhibit the reactivation of CMV which occurs locally in the 
mammary gland of the lactating mother after delivery.  
 
 
CMV infection in premature infants 
 
CMV excretion into urine is observed between days 30 
and 120, a time during which most infants with very low 
birth weight are still hospitalized and are susceptible to 
respiratory or other acute infections.  Early onset of CMV 
infection occurred only in extremely immature, preterm 
infants, and it was associated with a symptomatic course 
(Hamprecht et al., 2001).
 
Perinatal CMV infection often 
involves the hepatobiliary tract but not usually cause 
clinical manifestations. The symptoms were almost 
similar to previous descriptions of groups of neonates 
(Dworsky et al., 1982; Kumar et al., 1984).   
Symptomatic congenital infections by CMV usually 
occur in only 0.01% to 0.04% of all newborns.   As 
demonstrated by Prosch et al. (2002),
 
the total incidence 
of CMV in preterm infants was 18%.  Sawyer et al. 
(1987) as well as Vochem et al. (1998) observed CMV 
infection in 33% and 25% of preterm infants, 
respectively.  Using the more insensitive method of CMV 
isolation in cell culture, Yeager et al. (1983)
 
found a CMV 
incidence of 17%.  Hamprecht et al. (2001)
 
observed 
postnatal CMV infections in 37% (33/90) of preterm 
infants from seropositive, breastfeeding mothers.  In all 
these studies, the overall rate of CMV infection in 
preterm infants was higher.   
The clinical outcome of CMV infection in preterm 
newborns is variable, ranging from asymptomatic 
infection to fatal life-threatening diseases, such as 
sepsis-like disease (Kumar et al., 1984).However, a 
recent attempt to prevent maternal and nosocomial CMV 
transmission from occurring in premature neonates by 
administrating intravenous immunoglobulins failed 




Association with chronic lung diseases
 
      
Relationship between bronchopulmonary dysplasia 
(BPD) and congenital infection by pathogens such as 
Ureaplasma urealyticum, Chlamydia trachomatis, 
Mycoplasma hominis, or CMV has been speculated 
(Sawyer et al., 1987; Pierce and Bancalari, 1995; 
Numazaki et al., 1986; Iles et al., 1996; Wang et al., 
1995). Sawyer et al. (1987) reported an association 
between CMV infection and BPD. Infants with CMV 
infection, especially those with prenatal and postnatal 
infection, were significantly longer on ventilation than 
those without infection.The incidence of chronic lung 
diseases (CLD) in pre and post natally infected infants is  




higher compared with those infants for which the time of 
infection remained unclear. All of the infants with the 
clinical symptom complex had underlying CLD and all 
had received multiple blood transfusions during their 
hospitalization (Ballard et al., 1979).   Acquired CMV may 
be relatively common in sick preterm infants and should 
be distinguished from other causes of rapid deterioration. 
CMV frequently may cause active infection in preterm 
infants. CMV can colonize the upper respiratory tract.  
CMV may increase the risk of developing CLD including 
BPD in individual patients, especially in very immature 
infants. CMV induce early lung inflammation (Grundy et 
al., 1987) associated with increased expression of 
proinflammatory cytokines and chemokines. CMV may 
also trigger inflammatory processes in the immature 
lung, supporting the development of CLD such as BPD. 
The pro inflammatory cytokine TNF- stimulates 
expression of CMV immediate early (IE) proteins which 
are known to trigger inflammatory processes.Thus, active 
CMV infection may not only promote development of 
BPD but, in turn, CMV replication may be enhanced in 
the BPD lung by an inflammatory process.  
 
 
Association with breast milk and breastfeeding  
      
If breastfed preterm infants may be more likely than term 
infants to have asymptomatic CMV infection, preterm 
infants born vaginally acquired CMV infection also may 
develop symptomatic infection.  Breastfed preterm 
infants without enough serum titers of transplacental 
antibodies to CMV may be more likely to have a 
symptomatic infection.  It was suggested that about 40% 
of the breast-fed children acquire CMV via breast milk 
and breastfeeding during the first year of their lives 
(Minamishima et al., 1994).This mother-to-infant 
transmission of CMV may have certain protective effects 
on congenital CMV disease in the offspring.  However, it 
was also estimated that infants who are not breastfed 
have a six fold greater risk of dying from infectious 
diseases in the first 2 months of life than those who are 
breasted in less developed countries. 
After preterm infants who were CMV-seronegative 
were fed banked human milk that was either pasteurized 
or frozen, no infections were observed (Wang et al., 
1995). Pasteurization and freezing to    -20°C  for 3 days 
inactivated CMV in naturally infected raw human milk 
(Friis and Anderson, 1982; Welsh et al., 1979; Goldblum 
et al, 1984; Speer et al., 1986).This procedure may 
inactivate CMV in human milk without affecting the 
nutritional and immunological qualities of human breast 
milk.   
Although one might conceivably remove cell 
associated virus by filtering, free viral particles are 
difficult to eliminate. Pasteurization to 62.5°C will destroy 
infectious viral particles, but this also alters milk 





terms is often limited by the requirement for scrupulous 
hygiene (Lawrence, 1999; Wright and Feeney, 1998). 
 
  
Immunological factors may be associated with the 
pathogenesis of neurological and other sequelae in 
CMV-infected infants (Numazaki et al., 2002).It is 
possible that progression of neurologic complications is 
related to the persistent viral infection and replication of 
CMV or host immunological response to infection. 
Protective mechanisms of the innate and cellular immune 
system at work during lactation could potentially be 
exploited by vaccination. Most of seropositive 
breastfeeding mothers had selective reactivation of CMV 
in their breast milk with an incidence of acquired CMV 
infection in the neonatal unit.The rate of CMV acquisition 
in the neonatal unit appears to be high in which did not 
take preventive measures against CMV.   
 Hamprecht et al.  (2001)  have reported that 52% of 
mothers in their study were CMV-seropositive, and 22% 
of uninfected infants exposed to CMV-infected breast 
milk acquired the virus. The only difference in CMV 
specific preventive measures taken between these 
studies was the routine freezing of mother's milk at -20°C 
in the neonatal unit when an excess of milk was 
available. This milk was then used at a later date, usually 
after 72 hours of freezing at -20°C.A study by Friis and 
Anderson (1982) previously showed that freezing of 
breast milk at -20°C for more than 72 hours reduces 
CMV viral titers by 99%. Another showed that overnight 
freezing of breast milk at -20°C reduced CMV infectivity 
of milk by 90%, and storage over seven days reduced 
CMV infectivity by 100% (Stagno et al., 1980).Routine 
freezing of breast milk at -20°C may reduce transmission 
of CMV from breast milk of seropositive mothers to their 





CMV is an agent which causes CID in infants who have 
acquired the virus in utero, and causes severe systemic 
disorders due to viral reactivation in patients who are 
immuno compromised due to HIV-1 infection, organ 
transplantation, and immunosuppressive chemotherapy.  
The increase in the popularity of breastfeeding and use 
of child care arrangements are having a major effect on 
the epidemiology of cytomegalovirus infections (Stagno 
et al., 1994). We previously conclude that CMV excreted 
into milk whey may be more important in vertical infection 
than that of milk cells infected with CMV for breast-fed 
infants (Numazaki et al., 2001).  
In prospective studies there was a high incidence of 
CMV infection in preterm infants from seropositive and 
negative mothers. The most premature infants are at 
greatest risk of acquiring an early and symptomatic CMV 
infection. Term infants can be breast-fed when the 
mother is shedding virus in her milk because of the 





Premature infants with low concentration of 
transplacental antibodies can acquire the disease from 
the fresh breast milk containing the virus. Freezing 
breast milk at -20 degrees C for 7 days can inactivate the 
virus and this may be a protective for the preterm infant 
until the titer of serum antibody against CMV received by 
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